IQDF holdings

Computed by this site from the fund's SEC Form N-PORT filing; what the measure does not tell you · every fund in one table · hold it with other funds? X-ray the mix. Pricing: 97.88% at a quoted market price (level 1), 36 issuer countries, 3% restricted securities.

IQDF's largest investment is Taiwan Semiconductor Manufacturing Co. Ltd at 4.19% of net assets. Advantest Corp and Tokyo Electron Ltd follow; the three together are 7.93%. Ten companies are 19.9% of the fund; the other 215 share the rest. Among the 721 equity funds measured here, IQDF behaves like 100.1 holdings against a median of 42.4 — 2.4 times the median. Across 27 quarterly filings IQDF has held roughly steady since 2019-10-31 (126.3 then, 106.4 now). Between the 2026-01-31 and 2026-04-30 filings 25 positions were added and 40 dropped; 21.1% of the weight moved. Japan is the largest country at 11.98% of the portfolio, across 36 countries in the filing.

Each sentence is read from the fund's own SEC filing; the class median is computed across the comparable equity funds on this site. Nothing here is a view on the fund.

Between 2019-10-31 and 2026-04-30, IQDF went from behaving like 126.3 equally weighted positions to 106.4 — 16% fewer, while its top ten went from 14.79% to 18.49% of net assets. Read across the funds on the concentration-over-time table.

One row per filed reporting period, newest first, read from EDGAR. Quarterly because that is the public filing cadence. Rows marked * are published but held out of the comparison above; the methodology page says when and why.

IQDF's filing lists 232 positions including 2.15% of net assets in securities-lending cash collateral. Counted as filed the fund reads 98.3 effective holdings with a top ten of 20.18%; on its own investments — the figure above — it reads 100.1 with a top ten of 19.9%. The collateral is matched by a liability and is not a holding the fund chose; since 2026-09-18 every figure on this site sets it aside (methodology). Both numbers are in the data.

The 15 largest of 225 positions in IQDF's Form N-PORT, weight as a share of net assets, securities-lending collateral excluded. Every position, every quarter: IQDF.csv.gz.

Share of IQDF's own investments by the issuer country the filer reported (incorporation, not revenue). Each country links to every fund that holds it.

Monthly total returns from Item B.5 of IQDF's own filings, 81 months on record. Not computed here and not from a price feed.

Cross-checked against a series computed separately from prices: median difference 0.48 percentage points over 81 months, which is roughly the distributions. Every month with the filing it came from: IQDF.json · all funds.

The fund lends its holdings, and Item B.4.a of the filing names every firm holding them. At 2026-07-31, $163m was out to 18 borrowers. The largest, GOLDMAN SACHS INTERNATIONAL, held 36.1% of it.

The filing reports no cash collateral position against this loan. Collateral taken in a form the fund does not hold as a position does not appear in N-PORT, so this is silence rather than absence. What the collateral figure can and cannot show. Every quarter IQDF has filed, with each borrower: IQDF.json · all funds.

229 positions became 214: 25 added (11.3% of the fund at the later date), 40 dropped (10.9% at the earlier date). Half the sum of all weight changes, a turnover proxy: 21.1%. Positions are matched on identifiers, so a security whose identifier changed shows as one drop and one add. Every filing of IQDF compared this way, as a feed: changes.xml · all funds: filings received.

New: Roche Holding AG (1.79%), NatWest Group plc (0.92%), Holcim AG (0.89%), Wolters Kluwer NV (0.85%), MS&AD Insurance Group Holdings, Inc. (0.78%), Ambev SA (0.73%). Gone: Roche Holding AG (2.04%), New China Life Insurance Co. Ltd. (0.81%), Cathay Pacific Airways Ltd. (0.68%), Cheng Shin Rubber Industry Co. Ltd. (0.63%), Shin-Etsu Chemical Co. Ltd. (0.46%), Takeda Pharmaceutical Co. Ltd. (0.39%).

97.9% of IQDF is carried at a quoted market price (fair-value level 1). Categories and levels are the filer's, from Form N-PORT; what a low level-1 share does and does not mean is in the measure's page.

A position count cannot describe a fund that uses derivatives, because a swap is filed at its unrealised gain, not its exposure. These are the notionals the fund itself reported, against net assets of $1.10B. Notional of an interest-rate or currency swap is not equity exposure.

Full detail for every fund that files derivatives: leverage.json (CC BY 4.0).

Every measured equity fund lined up by how many holdings it behaves like; these sit either side of IQDF (100.1). Same filings, same arithmetic. Position in this list says nothing about which fund is better.